Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 14, 2009 - Issue 1
Submit an article Journal homepage
204
Views
7
CrossRef citations to date
0
Altmetric
Review

Emerging drugs for psoriasis

Luigi Naldi Centro Studi GISED; Department of Dermatology, Ospedali Riuniti, Largo Barozzi 1, 24100 Bergamo, Italy +39 035400625; +39 035266458; [email protected]
, MD &
Giovanna Raho Centro Studi GISED
, Sc Biol
Pages 145-163 | Published online: 27 Feb 2009

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Esther A. Balogh, Arjun M. Bashyam, Rima I. Ghamrawi & Steven R. Feldman. (2020) Emerging systemic drugs in the treatment of plaque psoriasis. Expert Opinion on Emerging Drugs 25:2, pages 89-100.
Read now
Peter van de Kerkhof, Jonathan Barker, Christopher E. M. Griffiths, Alan Menter, Craig Leonardi, Melodie Young, Lajos Kemeny, Carlo Pincelli, Hervé Bachelez, Andreas Katsambas, Mona Ståhle, Elizabeth J. Horn & Wolfram Sterry. (2011) Improving clinical trial design in psoriasis: Perspectives from the global dermatology community. Journal of Dermatological Treatment 22:4, pages 187-193.
Read now
Ignazio Olivieri, Salvatore D'Angelo, Carlo Palazzi, Ennio Lubrano & Pietro Leccese. (2010) Emerging drugs for psoriatic arthritis. Expert Opinion on Emerging Drugs 15:3, pages 399-414.
Read now

Articles from other publishers (4)

Lori S. Kim, Jashin J. Wu & George Han. (2021) Deucravacitinib for Psoriasis. Current Dermatology Reports 10:1, pages 1-5.
Crossref
Yvonne Y. Li, Jianghong An & Steven J. M. Jones. (2011) A Computational Approach to Finding Novel Targets for Existing Drugs. PLoS Computational Biology 7:9, pages e1002139.
Crossref
Alexandra K. Golant & Emma Guttman-Yassky. (2018) Psoriasis Treatments: A Review of the Current Research Pipeline. Psoriasis Forum 17a:1, pages 11-23.
Crossref
Donald J. AbrahamMarcia I. Dawson. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 369 546 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.